Industry News
Biotechnology Industry News
Capricor culls COVID-19 vax work but eyes phase 3 for Duchenne therapy
Capricor culls COVID-19 vax work but eyes phase 3 for Duchenne therapy klahucik Thu, 03/10/2022 - 14:07
MorphoSys cans US R&D to consolidate work in Germany, taking $254M charge
MorphoSys cans US R&D to consolidate work in Germany, taking $254M charge mbayer Thu, 03/10/2022 - 13:36
Selecta back in phase 1 gene therapy saddle after clinical hold lift, plans to reboot ‘expeditiously’
Selecta back in phase 1 gene therapy saddle after clinical hold lift, plans to reboot 'expeditiously' mbayer Thu, 03/10/2022 - 10:18
Moderna doses 2nd arm of phase 2 booster study combining Spikevax with omicron-busting shot
Moderna doses 2nd arm of phase 2 booster study combining Spikevax with omicron-busting shot aarmstrong Thu, 03/10/2022 - 09:39
Roche-partnered Scenic Biotech snags $31M to study 3 rare disease drugs
Roche-partnered Scenic Biotech snags $31M to study 3 rare disease drugs klahucik Thu, 03/10/2022 - 09:25
Morningside rolls up a pair of biotechs to birth clinical-phase inflammatory disease player
Morningside rolls up a pair of biotechs to birth clinical-phase inflammatory disease player ntaylor Thu, 03/10/2022 - 09:09
Venatorx hits goal in antibiotic phase 3, clearing path to FDA
Venatorx hits goal in antibiotic phase 3, clearing path to FDA ntaylor Thu, 03/10/2022 - 08:06
Intellia’s CRISPR-engineered cell therapy secures FDA orphan drug status after AML trial launch
Intellia's CRISPR-engineered cell therapy secures FDA orphan drug status after AML trial launch klahucik Wed, 03/09/2022 - 16:31
We have achieved peak biotech formation. It’s time for ‘musical chairs’
We have achieved peak biotech formation. It's time for 'musical chairs' aarmstrong Wed, 03/09/2022 - 14:32
Twist’s antibodies to wind up with Kriya’s AAV gene therapies in new pact
Twist's antibodies to wind up with Kriya's AAV gene therapies in new pact klahucik Wed, 03/09/2022 - 10:25
BeiGene’s hematology CMO jumps to steer pipeline changes at Prelude
BeiGene's hematology CMO jumps to steer pipeline changes at Prelude klahucik Wed, 03/09/2022 - 09:04
J&J’s long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pact
J&J's long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pact ntaylor Wed, 03/09/2022 - 08:46
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulators
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulators ntaylor Wed, 03/09/2022 - 05:10
BioNTech-Regeneron add 3rd tumor type to partnership testing cancer vaccines with Libtayo
BioNTech-Regeneron add 3rd tumor type to partnership testing cancer vaccines with Libtayo mbayer Tue, 03/08/2022 - 10:37
Sanofi deploying $1B to turn France into ‘pioneer mRNA nation’
Sanofi deploying $1B to turn France into 'pioneer mRNA nation' klahucik Tue, 03/08/2022 - 09:53
Creyon joins wave of AI biotechs with $40M to create ‘on demand’ RNA-based medicines
Creyon joins wave of AI biotechs with $40M to create 'on demand' RNA-based medicines klahucik Tue, 03/08/2022 - 08:59
Valneva heads to FDA as durability of chikungunya vaccine holds up in phase 3
Valneva heads to FDA as durability of chikungunya vaccine holds up in phase 3 ntaylor Tue, 03/08/2022 - 08:11
Late-stage biotechs, Kurma has €160M to help you clear the final hurdles in the race to market
Late-stage biotechs, Kurma has €160M to help you clear the final hurdles in the race to market ntaylor Tue, 03/08/2022 - 05:45
Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact
Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact aarmstrong Mon, 03/07/2022 - 16:53
J&J to celebrate Carvykti nod without Janssen oncology chief as Serge Messerlian nabs Teon CEO job
J&J to celebrate Carvykti nod without Janssen oncology chief as Serge Messerlian nabs Teon CEO job mbayer Mon, 03/07/2022 - 13:40